Modification of Amphotericin B's Therapeutic Index by Increasing Its Association with Serum High‐Density Lipoproteins

Annals of the New York Academy of Sciences

Volumn 730, Issue 1, 1994, Pages 93-106

  WASAN, KISHOR M ^a,b   LOPEZ‐BERESTEIN, GABRIEL ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN RECEPTOR; INTRALIPID; LIPOSOME; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANTIFUNGAL ACTIVITY; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; KIDNEY CELL; LIPOPROTEIN BLOOD LEVEL; NEPHROTOXICITY; NONHUMAN; RAT; TISSUE DISTRIBUTION;

EID: 0028048177     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1994.tb44242.x     Document Type: Article

References (41)

1. Amphotericin B
2. Adverse effect of amphotericin B administration on renal hemodynamics in the rat neurohumoral mechanisms and influence of calcium channel blocker
3. Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients
4. On the anatomy of amphotericin B‐cholesterol pores in liquid bilayer membranes
5. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome‐encapsulated amphotericin B.
6. Altered tissue distribution of amphotericin B by liposomal encapsulation: Comparison of normal mice to mice infected with Candida albicans.
7. Liposomes as carriers of antifungal drugs
8. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats
9. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes
10. Interactions of liposome‐incorporated amphotericin B with kidney epithelial cells
11. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture
12. Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins
13. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism
14. Efficacy and toxicity of liposomal cyclosporine
15. Delivery of lipophilic drugs using lipoproteins
16. Serum lipoproteins analysis
17. Interaction of plasma proteins and lipoproteins with amphotericin B
18. Effects of serum lipoproteins on damage to erythrocytes and Candida albicans cells by polyene antibiotics.
19. Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B‐induced toxicity in rabbits
20. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients
21. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis
22. Surface diffusion in human serum lipoproteins
23. Human apolipoprotein A‐I forms thermally stable complexes with anionic but not with zwitterionic phospholipids
24. Influence of lipoprotein‐associated amphotericin B on its renal cytotoxicity and antifungal activity
25. Unusual lipid structures selectively reduce the toxicity of amphotericin B
26. Amphotericin B‐phospholipid interactions responsible for reduced mammalian cell toxicity
27. One‐sided action of amphotericin B on cholesterol‐containing membranes is determined by its self‐association in the medium
28. Circular dichroism for the determination of amphotericin B binding to liposomes
29. Affinity of amphotericin B for phosphatidyl‐choline vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.
30. Changes of high density lipoprotein subfraction concentration and composition by Intralipid in vivo and by lipolysis of Intralipid in vitro.
31. Appearance and characterization of lipoprotein X during continuous Intralipid infusions in the neonate
32. Identification of lipoprotein X‐like particles in rat plasma following Intralipid infusion
33. Intravascular metabolism of an artificial transporter of triacylglycerols
34. Alteration of lipoprotein profile during total parenteral nutrition with Intralipid 10%
35. Effects of Intralipid infusion on rat serum lipoproteins
36. Serum concentration and tissue distribution of free and liposomal amphotericin B in rats on continuous Intralipid infusion
37. Effects of Intralipid‐induced hypertriglycemia on plasma high‐density lipoprotein metabolism in the cynomolgus monkey
38. Effect of total parenteral nutrition with intravenous fat on lipid and high density lipoprotein heterogeneity in neonates
39. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes
40. Synthetic high density lipoprotein particles: Application to studies of the apoprotein specificity for selective uptake of cholesterol esters